Study 3 of 16 for search of: "Von Hippel-Lindau syndrome"
Previous Study Return to Search Results Next Study

Full Text View
Tabular View
Contacts and Locations
No Study Results Posted
Related Studies
Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow
This study is currently recruiting participants.
Study NCT00330564.   Last updated on November 14, 2008.
Information provided by M.D. Anderson Cancer Center
Please refer to this study by its ClinicalTrials.gov identifier: NCT00330564
Contacts
Contact: Cherie A Perez, BS, RN 713-563-1602
Contact: Eric Jonasch, MD 713-792-2830

Locations
United States, Texas
U.T.M.D. Anderson Cancer Center Recruiting
Houston, Texas, United States, 77030
Contact: Cherie A Perez, BS RN     713-563-1602        
Contact: Surena Matin, M.D., FACS     713-792-3250        
Sub-Investigator: Surena F Matin, M.D., FACS            
Principal Investigator: Eric Jonasch, MD            
Sponsors and Collaborators
M.D. Anderson Cancer Center
Pfizer
Investigators
Principal Investigator: Eric Jonasch, MD U.T.M.D. Anderson Cancer Center




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services